Craft

Hofseth BioCare

Stock Price

KR1.4

2024-10-29

Market Capitalization

KR568.9 M

2024-10-29

Revenue

KR256.3 M

FY, 2025

Hofseth BioCare Summary

Company Summary

Overview
Hofseth BioCare, a biotech company, develops, manufactures, markets and sells marine ingredients and finished products for humans and pets. Its products include OmeGo salmon oil; ProGo, a salmon protein hydrolysate powder used as a fast absorbing protein supplement; and CalGo, a marine calcium powder produced from salmon bones that enhances bone density and bone deposition in older individuals.
Type
Public
Status
Active
Founded
2000
HQ
Ålesund, NO | view all locations
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Roger Hofseth

    Roger Hofseth, CEO

    • Jon Olav Ødegård

      Jon Olav Ødegård, CFO

      • Karl Inge Slotsvik

        Karl Inge Slotsvik, COO

        • Bomi Framroze

          Bomi Framroze, Chief Scientific Officer

          LocationsView all

          1 location detected

          • Ålesund, Møre og Romsdal HQ

            Norway

            Kipervikgata

          Hofseth BioCare Financials

          Summary Financials

          Revenue (FY, 2025)
          kr256.3M
          Gross profit (FY, 2025)
          kr96.1M
          Net income (FY, 2025)
          (kr134.9M)
          Cash (FY, 2025)
          kr67.1M
          EBIT (FY, 2025)
          (kr87.7M)
          Enterprise value
          $861.8M

          Footer menu